Prognostic impact of osteosarcopenia in patients with head and neck cancer undergoing radical resection and reconstructive surgery
Related Experiment Video
Updated: Sep 13, 2026

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
Takahiro Hongo1, Yusuke Watanuki2, Yusuke Hirano2
1Department of Head and Neck Surgery, National Kyushu Cancer Center, Fukuoka, Japan; Department of Otorhinolaryngology-Head and Neck Surgery, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Purpose:
Osteosarcopenia, i.e., the coexistence of sarcopenia and osteopenia, has emerged as a marker of systemic frailty. The prognostic significance of osteosarcopenia in head and neck cancer (HNC) patients who undergo radical surgery with reconstruction is unclear.
Methods:
We retrospectively analyzed the cases of 127 HNC patients who underwent radical resection and reconstructive surgery. We used preoperative computed tomography to measure the skeletal muscle index (SMI) at the L3 level and L1 vertebral Hounsfield units (HU) to assess bone mineral density. Osteopenia was defined using a receiver operating characteristic (ROC)-derived cutoff of 107 HU. Sarcopenia was defined according to established criteria. Osteosarcopenia was defined as the coexistence of both osteopenia and sarcopenia. Overall survival (OS) and disease-free survival (DFS) were evaluated by a Kaplan-Meier analysis and Cox proportional hazards models.
Results:
The SMI showed limited predictive ability for 2-year OS (AUC = 0.594); the L1 HU value demonstrated moderate performance (AUC = 0.667). Patients with osteosarcopenia had significantly worse OS (p < 0.001) and DFS (p = 0.0002) than those without. In a four-group analysis (normal, sarcopenia-alone, osteopenia-alone, and osteosarcopenia), the osteosarcopenia group showed the poorest survival. The multivariate analysis identified osteosarcopenia as an independent prognostic factor for OS (HR 3.91, 95%CI: 1.95-7.86, p = 0.0001) and DFS (HR 3.11, 95%CI: 1.75-5.53, p = 0.0001), along with the prognostic nutritional index.
Conclusion:
Preoperative osteosarcopenia is a strong independent prognostic factor in HNC patients undergoing reconstructive surgery. A combined assessment of muscle and bone status plus a nutritional evaluation may improve the risk stratification and perioperative management in this population.

